Publications

 

    • Detappe A, Kunjachan S, Rottmann J, Robar J, Tsiamas P, Korideck H, Tillement O, Berbeco R. AGuIX nanoparticles as a promising platform for image-guided radiation therapy. Cancer Nanotechnology. 2015; 6:4 (2 September 2015)
    • Chetty IJ, Martel MK, Jaffray DA, Benedict SH, Hahn SM, Berbeco R, Deye J, Jeraj R, Kavanuagh B, Krishnan S, Lee N, Low DA, Mankoff D, Marks LB, Ollendorf D, Paganetti H, Ross B, Siochi RAC, Timmerman RD and Wong J. Technology for Innovation in Radiation Oncology. International Journal of Radiation Oncology Biology Physics. 2015; 93 (3): 485-492.
    • Kunjachan S, Detappe A, Kumar R, Ireland T, Cameron L, Biancur D, Motto-Ros V, Sancey L, Sridhar S, Makrigiorgos GM, Berbeco RI. Nanoparticle mediated tumor vascular disruption: a novel strategy in radiation therapy. Nano Letters. 2015; 15(11): 7488-7496. 
    • Yip S, Rottmann J, and Berbeco RI. Beam's-eye-view imaging during non-coplanar lung SBRT. Medical Physics. 2015; 42 (12): 6776-6783 
    • Schuemann J, Berbeco R, Chithrani D, Cho SH, Kumar R, McMahon SJ, Sridhar S, and Krishnan S. Roadmap to clinical use of gold nanoparticles for radiosensitization. International Journal of Radiation Oncology Biology Physics. 2016; 94(1): 189-205.
    • Berbeco RI, Detappe A, Tsiamas P, Parsons D, Yewondwossen M, Robar J. Low Z target switching to increase tumor endothelial cell dose enhancement during gold nanoparticle-aided radiation therapy. Medical Physics. 2016; 43 (1) 436-442. 
    • Yip SF, Coroller TP, Sanford NN, Huynh E, Mamon H, Aerts HJWL, and Berbeco RI. Use of registration-based contour propagation in texture analysis for esophageal cancer pathologic response prediction. Physics in Medicine and Biology. 2016; 61 (2): 906-22. 
    • Kotb S, Detappe A, Lux F, Appaix F, Barbier E, Tran VL, Bonnel M, Gehan H, Lefranc F, Rodriguez-Lafrasse C, Berbeco R, Tillement O, and Sancey L. Gadolinium-based nanoparticles and radiation therapy for multiple brain melanoma metastases: proof of concept for a phase I trial. Theranostics. 2016; 6 (3): 418-427. 
    • Yip SF, Coroller TP, Sanford NN, Mamon HJ, Aerts HJWL, and Berbeco RI. Relationship between the temporal changes in positron-emission-tomography-imaging-based textural features and pathologic response and survival in esophageal cancer patients. Frontiers in Oncology. 2016; 6:72.
    • Rottmann J, Morf D, Fueglistaller R, Zentai G, Star-Lack J, Berbeco R. A novel EPID for enhanced contrast and detective quantum efficiency. Physics in Medicine and Biology. 2016; 61 (17): 6297-6306 
    • Detappe A, Kunjachan S, Sancey L, Motto-Ros V, Biancur D, Drane P, Guieze R, Makrigiorgos GM, Tillement O, Langer R, and Berbeco R. Advanced multimodal nanoparticles delay tumor progression with clinical radiation therapy. Journal of Controlled Release. 2016; July 14; 238: 103-113. 
    • Detappe A, Kunjachan S, Drane P, Kotb S, Myronakis M, Biancur D, Ireland T, Wagar M, Lux F, Tillement O, Langer R, and Berbeco R. Key clinical parameters for nanoparticle-mediated radiation dose amplification. Nature Scientific Reports. 2016; 6:34040. 

A complete listing of publications can be found at

http://www.ncbi.nlm.nih.gov/sites/myncbi/ross.berbeco.1/bibliograpahy/43658185/public/?sort=date&direction=ascending